Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. It also offers SMT-738, for combating multidrug resistant infections primarily carbapenem-resistant Enterobacteriaceae infections; and DDS-04 series for the potential treatment of infections caused by the Enterobacteriaceae. The company was founded in 2003 and is based in Cambridge, Massachusetts.
Over the last 12 months, insiders at Summit Therapeutics Inc. have bought $5.84M and sold $0 worth of Summit Therapeutics Inc. stock.
On average, over the past 5 years, insiders at Summit Therapeutics Inc. have bought $209.23M and sold $321,463 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Soni Manmeet Singh (Chief Operating Officer) — $5M. Dhingra Ankur (Chief Financial Officer) — $838,508. Zanganeh Mahkam (Chief Executive Officer) — $421,444.
The last purchase of 80,321 shares for transaction amount of $298,594 was made by Zanganeh Mahkam (Chief Executive Officer) on 2024‑03‑27.
2024-03-27 | Zanganeh Mahkam | Chief Executive Officer | 80,321 0.0113% | $3.72 | $298,594 | +17.38% | ||
2024-03-26 | Dhingra Ankur | Chief Financial Officer | 100,000 0.0143% | $3.75 | $375,000 | +17.38% | ||
2024-03-26 | Zanganeh Mahkam | Chief Executive Officer | 30,000 0.0043% | $3.75 | $112,500 | +17.38% | ||
2023-12-13 | Dhingra Ankur | Chief Financial Officer | 20,400 0.0027% | $2.17 | $44,254 | +74.04% | ||
2023-12-12 | Zanganeh Mahkam | Chief Executive Officer | 5,000 0.0007% | $2.07 | $10,350 | +86.30% | ||
2023-10-13 | Soni Manmeet Singh | Chief Operating Officer | 2.98M 0.4265% | $1.68 | $5M | +122.92% | ||
2023-03-08 | Zanganeh Mahkam | Co-CEO & President | 23.53M 4.2977% | $1.05 | $24.7M | +26.64% | ||
2023-03-07 | Dhingra Ankur | Chief Financial Officer | 196,362 0.0395% | $1.05 | $206,180 | +39.49% | ||
2023-03-06 | DUGGAN ROBERT W | Chief Executive Officer | 376.49M 75.2052% | $1.05 | $395.31M | +38.49% | ||
2022-08-16 | DUGGAN ROBERT W | Chief Executive Officer | 94.85M 61.3078% | $0.97 | $92M | +70.30% | ||
2022-08-16 | Zanganeh Maky | Co-CEO & President | 1.03M 0.6664% | $0.97 | $999,997 | +70.30% | ||
2022-08-16 | Dhingra Ankur | Chief Financial Officer | 37,685 0.0244% | $0.97 | $36,554 | +70.30% | ||
2021-05-12 | DUGGAN ROBERT W | Chief Executive Officer | 11.37M 12.0109% | $5.24 | $59.56M | -6.40% | ||
2021-05-12 | Zanganeh Maky | Chief Operating Officer | 389,077 0.4112% | $5.24 | $2.04M | -6.40% | ||
2020-11-30 | Sale | Powell David Jonathan | Chief Scientific Officer | 13,713 0.0195% | $4.44 | $60,886 | +36.67% | |
2020-11-27 | Sale | Powell David Jonathan | Chief Scientific Officer | 29,569 0.043% | $4.39 | $129,808 | +41.94% | |
2020-11-25 | Sale | Powell David Jonathan | Chief Scientific Officer | 12,070 0.0175% | $4.32 | $52,142 | +43.93% | |
2020-11-24 | Sale | Powell David Jonathan | Chief Scientific Officer | 11,374 0.0164% | $4.21 | $47,885 | +46.08% | |
2020-11-23 | Sale | Powell David Jonathan | Chief Scientific Officer | 6,987 0.01% | $4.40 | $30,743 | +39.77% | |
2020-11-06 | DUGGAN ROBERT W | Chief Executive Officer | 14.07M 20.8007% | $3.34 | $47M | +89.54% |
Soni Manmeet Singh | Chief Operating Officer | 2976190 0.4265% | $7.77 | 1 | 0 | |
Zanganeh Mahkam | Chief Executive Officer | 24923800 0.0709% | $7.77 | 6 | 0 | +30.18% |
Dhingra Ankur | Chief Financial Officer | 354958 0.0365% | $7.77 | 4 | 0 | +54.89% |
DUGGAN ROBERT W | Chief Executive Officer | 552354161 79.1507% | $7.77 | 4 | 0 | +47.98% |
Powell David Jonathan | Chief Scientific Officer | 0 0% | $7.77 | 0 | 5 |
BlackRock | $40.67M | 1.4 | 9.82M | +0.66% | +$264,786.11 | <0.01 | |
State Street | $33.59M | 1.16 | 8.11M | +230.36% | +$23.42M | <0.01 | |
Fidelity Investments | $33.01M | 1.14 | 7.97M | +85,445.28% | +$32.98M | <0.01 | |
The Vanguard Group | $30.09M | 1.04 | 7.27M | +3.63% | +$1.05M | <0.01 | |
Geode Capital Management | $13.05M | 0.45 | 3.15M | +2.16% | +$276,271.19 | <0.01 | |
Northern Trust | $4.44M | 0.15 | 1.07M | -3.19% | -$146,452.50 | <0.01 | |
Charles Schwab | $4.21M | 0.15 | 1.02M | +6.57% | +$259,573.84 | <0.01 | |
Morgan Stanley | $2.87M | 0.1 | 692,541 | -1.67% | -$48,566.33 | <0.0001 | |
Goldman Sachs | $2.82M | 0.1 | 680,601 | +250.09% | +$2.01M | <0.01 | |
Rafferty Asset Management Llc | $2.69M | 0.09 | 650,286 | New | +$2.69M | 0.01 | |
Steward Partners Investment Advisory LLC | $2.51M | 0.09 | 606,500 | +1.08% | +$26,910.00 | 0.03 | |
Bank of Montreal | $2.72M | 0.08 | 589,566 | +2,141.7% | +$2.6M | <0.01 | |
Citigroup | $2.31M | 0.08 | 559,006 | +1,818.54% | +$2.19M | <0.01 | |
Federated Hermes | $2.28M | 0.08 | 551,769 | +4,380.1% | +$2.23M | 0.01 | |
Alps Advisors Inc | $2.05M | 0.07 | 494,924 | -7.04% | -$155,175.45 | <0.01 | |
UBS | $1.97M | 0.07 | 476,942 | +215.3% | +$1.35M | <0.01 | |
Barclays | $1.63M | 0.06 | 393,312 | +23.46% | +$309,393.35 | <0.01 | |
Bank of America | $1.62M | 0.06 | 390,343 | +219.19% | +$1.11M | <0.0001 | |
Nuveen | $1.53M | 0.05 | 369,925 | -34.6% | -$810,193.59 | <0.0001 | |
Sectoral Asset Management | $1.3M | 0.05 | 315,000 | +950% | +$1.18M | 0.54 | |
BNY Mellon | $1.25M | 0.04 | 301,699 | -11.92% | -$169,036.35 | <0.0001 | |
Wellington Management Company | $1.23M | 0.04 | 297,620 | New | +$1.23M | <0.0001 | |
Swiss National Bank | $1.14M | 0.04 | 275,000 | 0% | +$0 | <0.01 | |
JPMorgan Chase | $1.03M | 0.04 | 249,667 | -15.71% | -$192,667.44 | <0.0001 | |
Susquehanna International Group | $667,939.00 | 0.02 | 161,338 | -29.96% | -$285,709.54 | <0.01 | |
Jane Street Capital | $577,534.00 | 0.02 | 139,501 | +27.55% | +$124,754.73 | <0.01 | |
RhumbLine Advisers | $582,255.00 | 0.02 | 140,643 | +5.18% | +$28,698.13 | <0.01 | |
CalSTRS | $569,854.00 | 0.02 | 137,646 | -3.91% | -$23,196.40 | <0.01 | |
China Universal Asset Management Co., Ltd. | $558,258.00 | 0.02 | 134,845 | +66.33% | +$222,624.24 | 0.05 | |
AllianceBernstein | $505,121.00 | 0.02 | 122,010 | +0.94% | +$4,719.60 | <0.0001 | |
Legal & General | $486,939.00 | 0.02 | 117,618 | -1.17% | -$5,738.05 | <0.0001 | |
Ubs Asset Management Americas Inc | $474,411.00 | 0.02 | 114,592 | +98.26% | +$235,118.94 | <0.0001 | |
Credit Suisse | $459,863.00 | 0.02 | 111,078 | +2.52% | +$11,293.92 | <0.0001 | |
State of Wisconsin Investment Board | $423,911.00 | 0.02 | 102,394 | -11.34% | -$54,221.56 | <0.01 | |
Profund Advisors Llc | $418,202.00 | 0.01 | 101,015 | New | +$418,202.00 | 0.01 | |
Shell Asset Management Co | $379,000.00 | 0.01 | 91,609 | -3.48% | -$13,656.73 | 0.02 | |
HoyleCohen Wealth Management | $349,450.00 | 0.01 | 84,408 | +13.44% | +$41,400.10 | 0.03 | |
Janus Henderson | $315,943.00 | 0.01 | 76,590 | +0.02% | +$61.88 | <0.0001 | |
Invesco | $312,475.00 | 0.01 | 75,477 | +7.78% | +$22,554.74 | <0.0001 | |
The Manufacturers Life Insurance Company | $319,289.00 | 0.01 | 77,123 | +1.37% | +$4,318.02 | <0.0001 | |
Deutsche Bank | $296,117.00 | 0.01 | 71,526 | -2.34% | -$7,083.52 | <0.0001 | |
ProShares | $289,780.00 | 0.01 | 69,995 | +9.44% | +$24,984.96 | <0.01 | |
Hightower Advisors | $265,000.00 | 0.01 | 64,050 | +435.98% | +$215,558.16 | <0.0001 | |
MetLife Investment Management | $262,137.00 | 0.01 | 63,318 | 0% | +$0 | <0.01 | |
Css Llc Il | $265,846.00 | 0.01 | 64,214 | -46.32% | -$229,385.01 | 0.03 | |
Exchange Traded Concepts, LLC | $248,342.00 | 0.01 | 59,986 | -19.99% | -$62,037.89 | 0.01 | |
American International Group | $236,427.00 | 0.01 | 57,108 | -0.85% | -$2,028.60 | <0.01 | |
Susquehanna Fundamental Investments Llc | $202,351.00 | 0.01 | 48,877 | -43.31% | -$154,567.07 | 0.01 | |
Mercer Global Advisors Inc Adv | $204,000.00 | 0.01 | 49,202 | +1.87% | +$3,739.85 | <0.01 | |
New York State Common Retirement Fund | $200,000.00 | 0.01 | 48,325 | -0.25% | -$492.50 | <0.0001 |